Efficacy and tolerability of 1000–4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy-Reference-Cited by-同舟云学术

Efficacy and tolerability of 1000–4000 mg per day of levetiracetam as add-on therapy in patients with refractory epilepsy

Published:2000-12 Issue:2-3 Volume:42 Page:89-95
ISSN:0920-1211
Container-title:Epilepsy Research
language:en
Short-container-title:Epilepsy Research

Author:

Grant R.,Shorvon S.D.

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology

Reference12 articles.

1. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy;Gower;Epilepsy Res.,1995

2. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy;Klitgaard;Eur. J. Pharmacol.,1998

3. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats;Löscher;Eur. J. Pharmacol.,1993

4. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy;Löscher;J. Pharmacol. Exp. Ther.,1998

5. New antiepileptic drugs: a systematic review of their efficacy and tolerability;Marson;Br. Med. J.,1996

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A review of the pharmacology and clinical applications of levetiracetam in dogs and cats;Journal of Veterinary Emergency and Critical Care;2023-11-21

2. Animal Models of Drug-Resistant Epilepsy as Tools for Deciphering the Cellular and Molecular Mechanisms of Pharmacoresistance and Discovering More Effective Treatments;Cells;2023-04-24

3. Optimization of levetiracetam dosing regimen in critically ill patients with augmented renal clearance: a Monte Carlo simulation study;Journal of Intensive Care;2022-04-21

4. Retrospective Study of the Serum Level of Levetiracetam in Focal Epilepsy Related to Seizure Frequency and Side Effects in a Single Center: A Preliminary Study;Epilia: Epilepsy and Community;2022-03-31

5. Is the anticonvulsant activity of levetiracetam dose-dependent?;Seizure;2020-12